With the discovery of this mechanism of mM-CSF tumor cell death, clinical trials can be designed in which tumor cells are first killed through activation of paraptosis-inducing pathways; i.e. BK channel activation or via release of reactive oxygen species. This evidence concerns the gene KCNMA1 and neoplasm.